skip to main content
For ProvidersNews & UpdatesImportant Prescriber Information Update on Singulair


Important Prescriber Information Update on Singulair

Submitted by admin on Wed, 09/05/2012 - 16:08

Provider Incentive Payment

Prescriber Communication

Date: September 5, 2012

Effective Date: September 10, 2012


What You Need to Know

RightCare from Scott & White Health Plan is the Medicaid Managed Care Program provided by Scott & White Health Plan (SWHP) which provides both medical and pharmacy benefits effective March 1, 2012.


Singulair – Preferred Drug List Status Change

Effective September 10, 2012 the PDL status of Singulair will move from preferred to non-preferred. The generic substitute, Montelukast, will become the preferred agent. The only exception will be Singulair granules, which will remain preferred as no generic is currently available for this dosage form. When the granules become available in generic form, the brand granules will be changed to non-preferred.

Please note: This is for the RightCare Medicaid Managed Care line of business ONLY. This PDL status change does not affect any other line of business associated with Scott and White Health Plan.


Additional Resources

The Texas Medicaid formulary and Preferred Drug List (PDL) created and maintained by Texas Vendor Drug Program can be found at

Please visit our website at for additional information and updates from RightCare from Scott & White Health Plan.